Ortivus AB Share Price Nasdaq Stockholm

ORTI A

SE0000188930

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 17:00:00 25/09/2026 BST			5-day change	1st Jan Change
2.000 ^SEK	+5.26%		+20.48%	+53.85%

08-25	Ortivus AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-25	Calendar Tuesday, August 25	FW

Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Companyâ€™s customer base includes mainly ambulance services and emergency departments.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-13 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
25/09/26	SEK 2.000	+5.26%	408
22/09/26	SEK 1.900	+14.46%	500

Delayed Quote Nasdaq Stockholm

More quotes

As early as today, start finding the best investment opportunities!

Market Cap	144M 14.48M 12.74M 12.04M 10.92M 20.51M 1.39B 20.63M 55.69M 709M 54.36M 53.19M 2.28B	P/E 2024	-2.47x	P/E 2025	-2.86x
Enterprise Value	155M 15.55M 13.67M 12.93M 11.73M 22.03M 1.49B 22.15M 59.8M 762M 58.37M 57.11M 2.45B	EV / Sales 2024	1.19x	EV / Sales 2025	1.61x
Free-Float	28.2%	Yield 2024 *	-	Yield 2025	-

08-25	Ortivus AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-25	Calendar Tuesday, August 25	FW
05-07	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	Ortivus Exits H&E Solutions Shareholding	MT
05-04	Ortivus completes sale of its holding in H&E Solutions	RE
04-21	Ortivus AB Appoints Matti Zemack as New Chief Product Officer	CI
02-19	Ortivus AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-04	19 Stocks Reach New 52-Week Highs on the Stockholm Stock Exchange So Far Today	FW
01-13	Ponderus Invest has announced final outcome of cash offer to shareholders of Ortivus	RE
01-11	Ponderus Invest AB completed the acquisition of remaining 39.42% stake in Ortivus AB (OM:ORTI B).	CI
12-22	Ponderus announces approval regarding cash offer to shareholders of Ortivus	RE
12-18	Ortivus: Independent bid committee unanimously recommends to not accept mandatory cash offer	RE
12-17	Ortivus: Appointment of Minni Raij as CFO	RE

08-25	Interim Report for Ortivus AB (publ) for the period April – June 2026	AQ
07-08	Ortivus : enhances MobiMed Platform with AI-powered documentation through new partnership with TORTUS AI	PU
05-27	PRESS RELEASE	AQ
05-07	Interim Report for Ortivus AB (publ) for the period January-March 2026	AQ
05-04	Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit	AQ

1 day	+5.26%
1 week	+20.48%
Current month	+4.17%
1 month	+6.38%
3 months	-13.79%
6 months	+6.10%
Current year	+53.85%

1 week	2	2.3
1 month	1.66	2.36
Current year	1.3	3.05
1 year	1.3	3.05
3 years	1.3	6.2
5 years	1.3	8.8
10 years	1.3	73.75

Ortivus AB Share Price Nasdaq Stockholm

Stocks

ORTI A

SE0000188930

Advanced Medical Equipment & Technology

Valuation: Ortivus AB

Chart: Ortivus AB

Latest news: Ortivus AB

Press Releases: Ortivus AB

Quotes and Performance

Price Extremes

Managers and Directors: Ortivus AB

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Gustaf Nordenhök CEO	Chief Executive Officer	-	31/12/2023
Minni Raij DFI	Director of Finance/CFO	-	15/02/2026
Gabriel Åhbeck CTO	Chief Tech/Sci/R&D Officer	55	31/12/2012

Director	Title	Age	Since
Peter Edwall BRD	Director/Board Member	71	31/12/2007
Anna Klevby Dalgaard BRD	Director/Board Member	47	31/12/2016
Jarnberg Ulf BRD	Director/Board Member	62	31/12/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORTIVUS AB	+5.26%	+20.48%	-	-	14.48M
THERMO FISHER SCIENTIFIC, INC.	+0.53%	+3.01%	+46.17%	+34.91%	251B
DANAHER CORPORATION	+1.27%	+5.32%	+22.99%	-8.03%	160B
INTUITIVE SURGICAL, INC.	+2.37%	+3.27%	-5.97%	+40.06%	147B
BOSTON SCIENTIFIC CORPORATION	+0.43%	+0.89%	-55.07%	-17.35%	63.93B
EDWARDS LIFESCIENCES CORPORATION	+0.63%	-1.71%	+13.88%	+24.11%	50.05B
AGILENT TECHNOLOGIES, INC.	+1.40%	+8.19%	+42.00%	+56.44%	49.4B
SIEMENS HEALTHINEERS AG	+0.43%	+3.77%	-14.82%	-19.08%	48.94B
WATERS CORPORATION	+2.17%	+4.49%	+51.84%	+60.86%	43.52B
ILLUMINA, INC.	+0.70%	+13.85%	+196.54%	+105.44%	41.06B
Average	+1.15%	+4.25%	+33.06%	+30.82%	94.9B
Weighted average by Cap.	+0.44%	+4.07%	+27.20%	+26.08%

	2024	2025
Net sales	80.41M 8.08M 7.1M 6.72M 6.09M 11.44M 775M 11.51M 31.06M 396M 30.32M 29.66M 1.27B	73.4M 7.37M 6.48M 6.13M 5.56M 10.44M 708M 10.5M 28.35M 361M 27.67M 27.08M 1.16B
Net income	-24.9M -2.5M -2.2M -2.08M -1.89M -3.54M -240M -3.56M -9.62M -122M -9.39M -9.19M -394M	-21.88M -2.2M -1.93M -1.83M -1.66M -3.11M -211M -3.13M -8.45M -108M -8.25M -8.07M -346M
Net Debt	30.75M 3.09M 2.72M 2.57M 2.33M 4.37M 296M 4.4M 11.88M 151M 11.59M 11.34M 486M	10.64M 1.07M 940K 889K 806K 1.51M 103M 1.52M 4.11M 52.33M 4.01M 3.92M 168M